Prescription pricing -- Law and legislation -- United States

Resource Information

The concept Prescription pricing -- Law and legislation -- United States represents the subject, aboutness, idea or notion of resources found in Indiana State Library.

The Resource Prescription pricing -- Law and legislation -- United States

Label: Prescription pricing -- Law and legislation -- United States

truePrescription pricing

trueLaw and legislation
trueUnited States

26 Items that share the Concept Prescription pricing -- Law and legislation -- United States

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes

Borrow it

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and for Medical Devices, to Enhance the Postmarket Authorities of the Food and Drug Administration with Respect to the Safety of Drugs, and for Other Purposes

Borrow it

An Act to Make Corrections with Respect to Food and Drug Administration User Fees

Borrow it

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002

Borrow it

Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007

Borrow it

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017

Borrow it

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003

Borrow it

Expanding coverage of prescription drugs in Medicare : hearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, April 9, 2003

Borrow it

Fairness to Contact Lens Consumers Act : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, on H.R. 2221, September 12, 2003

Borrow it

Fairness to Contact Lens Consumers Act : report (to accompany H.R. 3140) (including cost estimate of the Congressional Budget Office)

Borrow it

H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act : hearing before the Subcommittee on Federal Workforce, Postal Service, and the District of Columbia of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, first session, on H.R. 4489, to amend chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program, February 23, 2010

Borrow it

Medicaid prescription drug pricing : hearing before the Subcommittee on Health for Families and the Uninsured of the Committee on Finance, United States Senate, One Hundred First Congress, second session, on S. 2605 and S. 3029, September 17, 1990

Borrow it

Medicare prescription drug benefits : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, first session, June 11, 1991

Borrow it

Physician dispensing of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One hundredth Congress, first session on H.R. 2093 ... April 22, 1987

Borrow it

Prescription Drug Marketing Act of 1987 : report (to accompany H.R. 1207)

Borrow it

Prescription Drug Marketing Act of 1987 : report (to accompany H.R. 1207) (including cost estimate of the Congressional Budget Office)

Borrow it

Prescription drug and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills ..

Borrow it

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002

Borrow it

Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997

Borrow it

Requesting the President and directing the Secretary of Health and Human Services provide certain documents to the House of Representatives relating to estimates and analyses of the cost of the medicare prescription drug legislation : adverse report together with dissenting views (to accompany H.Res. 776) (including cost estimate of the Congressional Budget Office)

Borrow it

The Drug Competition Act of 2001 : report (to accompany S. 754)

Borrow it

The high cost of high prices for HIV/AIDS drugs and the prize fund alternative : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... May 15, 2012

Borrow it

Context

Context of Prescription pricing -- Law and legislation -- United States

Subject of

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and for Medical Devices, to Enhance the Postmarket Authorities of the Food and Drug Administration with Respect to the Safety of Drugs, and for Other Purposes
An Act to Make Corrections with Respect to Food and Drug Administration User Fees
Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002
Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003
Expanding coverage of prescription drugs in Medicare : hearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, April 9, 2003
Fairness to Contact Lens Consumers Act : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, on H.R. 2221, September 12, 2003
Fairness to Contact Lens Consumers Act : report (to accompany H.R. 3140) (including cost estimate of the Congressional Budget Office)
H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act : hearing before the Subcommittee on Federal Workforce, Postal Service, and the District of Columbia of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, first session, on H.R. 4489 ... February 23, 2010
H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act : hearing before the Subcommittee on Federal Workforce, Postal Service, and the District of Columbia of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, first session, on H.R. 4489, to amend chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program, February 23, 2010
Medicaid prescription drug pricing : hearing before the Subcommittee on Health for Families and the Uninsured of the Committee on Finance, United States Senate, One Hundred First Congress, second session, on S. 2605 and S. 3029, September 17, 1990
Medicare prescription drug benefits : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, first session, June 11, 1991
Physician dispensing of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One hundredth Congress, first session on H.R. 2093 ... April 22, 1987
Prescription Drug Marketing Act of 1987 : report (to accompany H.R. 1207)
Prescription Drug Marketing Act of 1987 : report (to accompany H.R. 1207) (including cost estimate of the Congressional Budget Office)
Prescription drug and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills ..
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007
Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997
Requesting the President and directing the Secretary of Health and Human Services provide certain documents to the House of Representatives relating to estimates and analyses of the cost of the medicare prescription drug legislation : adverse report together with dissenting views (to accompany H.Res. 776) (including cost estimate of the Congressional Budget Office)
The Drug Competition Act of 2001 : report (to accompany S. 754)
The high cost of high prices for HIV/AIDS drugs and the prize fund alternative : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... May 15, 2012
The high cost of high prices for HIV/AIDS drugs and the prize fund alternative : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session on ... S. 1137 .. and S. 1138 ... May 15, 2012.
The high cost of high prices for HIV/AIDS drugs and the prize fund alternative : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session on ... S. 1137 ... and S. 1138 ... May 15, 2012

Embed (Experimental)

Settings

Select options that apply then copy and paste the RDF/HTML data fragment to include in your application

Embed this data in a secure (HTTPS) page:

Layout options: Carousel Grid List Card

Include data citation:

<div class="citation" vocab="http://schema.org/"> Data from <a href="http://link.library.in.gov/resource/Oer7QkahEMY/">Prescription pricing -- Law and legislation -- United States</a> - <a property="url" href="http://link.library.in.gov/">Indiana State Library</a></div>

Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements

Preview

Cite Data - Experimental

Data Citation of the Concept Prescription pricing -- Law and legislation -- United States

Copy and paste the following RDF/HTML data fragment to cite this resource

<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.in.gov/resource/Oer7QkahEMY/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.in.gov/resource/Oer7QkahEMY/">Prescription pricing -- Law and legislation -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.in.gov/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.in.gov/">Indiana State Library</a></span></span></span></span></div>

Prescription pricing -- Law and legislation -- United States

Resource Information

The concept Prescription pricing -- Law and legislation -- United States represents the subject, aboutness, idea or notion of resources found in Indiana State Library.

Context

Subject of